Abstract
Background: While most infected people recovered completely from COVID-19 within a few weeks, a considerable proportion continues to experience symptoms after their initial recovery similar to SARS survivors. Intensive ongoing research has shed light on the pathogenesis of COVID-19 and the extent of damages caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) but the intermediate and long-term complications remain unclear. The objective of this study is to evaluate the glycemic and atherogenic status in non-hospitalized and recovered covid-19 individuals without underlying diseases prior to the infection.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
